Dataset Information
Brivaracetam add-on therapy for drug-resistant epilepsy.
Ontology highlight
ABSTRACT:
SUBMITTER: Bresnahan R
PROVIDER: S-EPMC8919456 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
Publications
Brivaracetam add-on therapy for drug-resistant epilepsy.
The Cochrane database of systematic reviews 20220314
<h4>Background</h4>This is an updated version of the Cochrane Review previously published in 2019. Epilepsy is one of the most common neurological disorders. It is estimated that up to 30% of individuals with epilepsy continue to have epileptic seizures despite treatment with an antiepileptic drug. These patients are classified as drug-resistant and require treatment with a combination of multiple antiepileptic drugs. Brivaracetam is a third-generation antiepileptic drug that is a high-affinity ...[more]